Single-Arm Phases 1 and 2 Trial of Niraparib in Combination With Pembrolizumab in Patients With Recurrent Platinum-Resistant Ovarian Carcinoma
JAMA Oncology | June 13, 2019 | Volume: 5 | Issue: 8 | Pages: 1141
10.1001/jamaoncol.2019.1048
| PMID 31194228